Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)
Public ClinicalTrials.gov record NCT00088192. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label, Non-Comparative Protocol for Use of Intravitreous Pegaptanib Sodium Injection Every 6 Weeks in Patients With Exudative Age-Related Macular Degeneration (AMD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To provide Pegaptanib sodium injection to patients with subfoveal choroidal neovascularization (CNV) secondary to AMD, who are unable to participate in any of the Sponsor's other clinical studies with this drug for AMD, until such time as the patient's lesion is considered to have resolved or stabilized in the opinion of the treating ophthalmologist, or product becomes commercially available.
Study identification
- NCT ID
- NCT00088192
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2004 (Type not available)
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Aug 30, 2005
Started 2004
United States locations
- U.S. sites
- 20
- U.S. states
- 17
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Doheny Eye Institute | Los Angeles | California | 90033 | — |
| Connecticut Retina Consultants, L.L.C. | Bridgeport | Connecticut | 06606 | — |
| New England Retina Associates | Hamden | Connecticut | 06518 | — |
| Retina Health Center | Fort Myers | Florida | 33901 | — |
| Retina Associates | New Orleans | Louisiana | 70155 | — |
| Cumberland Valley Retina Center | Hagerstown | Maryland | 21740 | — |
| New England Eye Center | Boston | Massachusetts | 02111 | — |
| Ophthalmic Consultants of Boston | Boston | Massachusetts | 02114 | — |
| Associated Retinal Consultants | Royal Oak | Michigan | 48073 | — |
| Eye Foundation of Kansas City | Kansas City | Missouri | 64108 | — |
| The Eye Center of Concord | Concord | New Hampshire | 03301 | — |
| Vitreo- Retinal Assoc. of NJ | Belleville | New Jersey | 07109 | — |
| Retina Associates of New Jersey, P.A. | Teaneck | New Jersey | 07666 | — |
| L.I. Vitreo-Retinal Consultants | Great Neck | New York | 11021 | — |
| Retina Associates of Cleveland Inc. | Lakewood | Ohio | 44107 | — |
| Dean A. McGee Eye Institute | Oklahoma City | Oklahoma | 73104 | — |
| The Casey Eye Institute | Portland | Oregon | 97239 | — |
| Palmetto Retina Center | Columbia | South Carolina | 29204 | — |
| Valley Retina Associates, P.A. | McAllen | Texas | 78503 | — |
| University of Vermont College of Medicine | Burlington | Vermont | 05401 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00088192, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 30, 2005 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00088192 live on ClinicalTrials.gov.